Evidence map›Paper›PMID 30596806›Full record

ArticlePloS one2018

Trichloroethene metabolite dichloroacetyl chloride induces apoptosis and compromises phagocytosis in Kupffer Cells: Activation of inflammasome and MAPKs.

Hui Wang, Gangduo Wang, G A Shakeel Ansari, M Firoze Khan

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Astaxanthin (AstaRealAdvances in therapy · 2025
    Trial
  4. Article
  5. Review
  6. Review
  7. Inflammasome Molecular Insights in Autoimmune Diseases.Current issues in molecular biology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. The safety of high-dose dexmedetomidine after cardiac surgery: a historical cohort study.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2022
    Article
  13. Article
  14. Mechanisms of Environment-Induced Autoimmunity.Annual review of pharmacology and toxicology · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hui WangDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas.
Gangduo WangDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas.
G A Shakeel AnsariDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas.
M Firoze KhanDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas.ORCID 0000-0002-0387-0584

Funding

Oxidative Stress and AutoimmunityR01ES016302 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI KHAN, M. FIROZE · 2008 to 2021
$3.5M
Trichloroethene Exposure and Autoimmune HepatitisR01ES026887 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI KHAN, M. FIROZE · 2017 to 2021
$1.7M
NIEHS NIH HHS R01 ES016302NIEHS NIH HHS R01 ES026887
6 · The paper itself

Abstract

Exposure to trichloroethene (TCE), an occupational and ubiquitous environmental contaminant, is associated with the development of several autoimmune diseases, including autoimmune hepatitis (AIH). However, mechanisms contributing to TCE-mediated AIH are not known. Earlier, we have shown that dichloroacetyl chloride (DCAC), one of the reactive metabolites of TCE with strong acylating capability, can elicit an autoimmune response at much lower dose than TCE in female MRL+/+ mice. Furthermore, Kupffer cells (KCs), the liver resident macrophages, are crucial for hepatic homeostasis, but can also participate in the immunopathogenesis of AIH. However, contribution of KCs in TCE-mediated AIH and the underlying mechanisms are not understood. We hypothesized that increased apoptosis and delayed clearance of apoptotic bodies, due to compromised KC function, will result in the breakdown of self-tolerance, autoimmunity, and ultimately AIH. Therefore, using an in vitro model of immortalized mouse KCs, we investigated the contribution of DCAC in TCE-mediated AIH. KCs were treated with different concentrations of DCAC and apoptosis was measured by Annexin V and PI staining. Also, the impact of DCAC on phagocytic potential of KCs was evaluated. Furthermore, markers of inflammasome (NLRP3 and caspase1) were analyzed by real-time PCR and Western blot analysis. DCAC treatment resulted in significantly increased early and late-stage apoptosis, accompanied with inflammasome activation (NLRP3 increases). DCAC treatment resulted in decreased phagocytic function of KCs in a dose-dependent manner, with reduced MFG-E8 levels (phagocytotic function). Furthermore, DCAC exposure led to induction of phos-ERK and phos-AKT signaling. These findings suggest that DCAC induces apoptosis and inflammasome activation, while compromising the phagocytic function of KCs. Our data support that increased apoptosis and impaired KC function by DCAC could be contributory to TCE-mediated AIH.

Indexed as

AnimalsApoptosisDose-Response Relationship, DrugEnzyme ActivationExtracellular Signal-Regulated MAP KinasesFemaleInflammasomesKupffer CellsMAP Kinase Signaling SystemMicePhagocytosisTrichloroethyleneExtracellular Signal-Regulated MAP KinasesInflammasomesTrichloroethylene

Identifiers

PMID30596806
PMCPMC6312261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.